Goelzer Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,100
| Closed | -$207K | – | 279 |
|
|
2025
Q3 | $207K | Sell |
2,100
-113
| -5% | -$11.2K | 0.01% | 242 |
|
|
2025
Q2 | $202K | Sell |
2,213
-212
| -9% | -$20.5K | 0.01% | 243 |
|
|
2025
Q1 | $274K | Sell |
2,425
-3,173
| -57% | -$339K | 0.02% | 219 |
|
|
2024
Q4 | $591K | Sell |
5,598
-47
| -0.8% | -$5.04K | 0.03% | 167 |
|
|
2024
Q3 | $609K | Sell |
5,645
-1,041
| -16% | -$114K | 0.03% | 161 |
|
|
2024
Q2 | $726K | Sell |
6,686
-896
| -12% | -$106K | 0.04% | 152 |
|
|
2024
Q1 | $1M | Sell |
7,582
-1,282
| -14% | -$160K | 0.06% | 141 |
|
|
2023
Q4 | $1.08M | Sell |
8,864
-2,594
| -23% | -$289K | 0.07% | 140 |
|
|
2023
Q3 | $1.29M | Sell |
11,458
-644
| -5% | -$81.8K | 0.09% | 131 |
|
|
2023
Q2 | $1.76M | Sell |
12,102
-743
| -6% | -$101K | 0.15% | 125 |
|
|
2023
Q1 | $1.66M | Sell |
12,845
-7,454
| -37% | -$936K | 0.14% | 131 |
|
|
2022
Q4 | $2.59M | Sell |
20,299
-975
| -5% | -$113K | 0.22% | 117 |
|
|
2022
Q3 | $2.22M | Sell |
21,274
-781
| -4% | -$85.7K | 0.22% | 114 |
|
|
2022
Q2 | $2.32M | Sell |
22,055
-2,747
| -11% | -$326K | 0.22% | 118 |
|
|
2022
Q1 | $3.17M | Sell |
24,802
-1,879
| -7% | -$226K | 0.27% | 110 |
|
|
2021
Q4 | $3.29M | Sell |
26,681
-625
| -2% | -$81.8K | 0.27% | 110 |
|
|
2021
Q3 | $3.88M | Sell |
27,306
-1,061
| -4% | -$156K | 0.34% | 92 |
|
|
2021
Q2 | $4.43M | Sell |
28,367
-10,446
| -27% | -$1.69M | 0.37% | 88 |
|
|
2021
Q1 | $6.03M | Sell |
38,813
-2,120
| -5% | -$328K | 0.53% | 58 |
|
|
2020
Q4 | $6.12M | Sell |
40,933
-875
| -2% | -$124K | 0.56% | 54 |
|
|
2020
Q3 | $5.53M | Sell |
41,808
-117
| -0.3% | -$15.3K | 0.51% | 57 |
|
|
2020
Q2 | $4.86M | Sell |
41,925
-2,391
| -5% | -$276K | 0.47% | 60 |
|
|
2020
Q1 | $4.35M | Buy |
44,316
+15,364
| +53% | +$2.01M | 0.5% | 59 |
|
|
2019
Q4 | $4.21M | Sell |
28,952
-10,748
| -27% | -$1.48M | 0.36% | 88 |
|
|
2019
Q3 | $5.29M | Sell |
39,700
-586
| -1% | -$75.7K | 0.48% | 68 |
|
|
2019
Q2 | $4.61M | Buy |
40,286
+228
| +0.6% | +$26.7K | 0.42% | 77 |
|
|
2019
Q1 | $4.97M | Sell |
40,058
-13,426
| -25% | -$1.53M | 0.47% | 69 |
|
|
2018
Q4 | $5.39M | Sell |
53,484
-944
| -2% | -$106K | 0.69% | 49 |
|
|
2018
Q3 | $6.95M | Sell |
54,428
-1,771
| -3% | -$211K | 0.77% | 45 |
|
|
2018
Q2 | $6.08M | Sell |
56,199
-1,664
| -3% | -$181K | 0.71% | 48 |
|
|
2018
Q1 | $6.13M | Sell |
57,863
-2,363
| -4% | -$274K | 0.73% | 41 |
|
|
2017
Q4 | $7.06M | Buy |
60,226
+501
| +0.8% | +$56.7K | 0.79% | 36 |
|
|
2017
Q3 | $6.79M | Sell |
59,725
-962
| -2% | -$111K | 0.8% | 38 |
|
|
2017
Q2 | $7.57M | Sell |
60,687
-1,671
| -3% | -$198K | 0.93% | 27 |
|
|
2017
Q1 | $7.39M | Sell |
62,358
-194
| -0.3% | -$22K | 0.92% | 28 |
|
|
2016
Q4 | $6.27M | Buy |
62,552
+5,459
| +10% | +$585K | 0.81% | 35 |
|
|
2016
Q3 | $7.21M | Sell |
57,093
-561
| -1% | -$69.3K | 0.97% | 23 |
|
|
2016
Q2 | $6.74M | Sell |
57,654
-1,283
| -2% | -$145K | 0.93% | 30 |
|
|
2016
Q1 | $6.1M | Buy |
58,937
+2,428
| +4% | +$235K | 0.87% | 27 |
|
|
2015
Q4 | $5.63M | Buy |
56,509
+15,387
| +37% | +$1.51M | 0.82% | 33 |
|
|
2015
Q3 | $3.75M | Buy |
+41,122
| New | +$4.12M | 0.6% | 63 |
|
Other funds holding ZBH
Goelzer Investment Management's ZBH Position: Q4 2025 in Review
Goelzer Investment Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,100 shares — an estimated $207K sold.
Goelzer Investment Management first reported a position in ZBH in Q3 2015 and held it in 41 quarters. The position peaked at $7.57M in Q2 2017. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Goelzer Investment Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Goelzer Investment Management sold 2,100 Zimmer Biomet shares in Q4 2025, an estimated $207K.
- Goelzer Investment Management first reported a position in Zimmer Biomet in Q3 2015 and held it in 41 quarters.
- Goelzer Investment Management's Zimmer Biomet position peaked at $7.57M in Q2 2017.
- 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Goelzer Investment Management's 13F filing for Q4 2025, filed 14 Jan 2026.